TY  - GEN
AU  - Vigon-Hernandez, Lorena
AU  - Rodríguez-Mora, Sara
AU  - Luna, Alejandro
AU  - Sandonis-Martin, Virginia
AU  - Mateos, Elena
AU  - Bautista, Guiomar
AU  - Steegmann, Juan Luis
AU  - Climent, Núria
AU  - Plana, Montserrat
AU  - Perez-Romero, Pilar
AU  - De Ory, Fernando de
AU  - Alcamí, José
AU  - García-Gutiérrez, Valentín
AU  - Planelles, Vicente
AU  - Lopez-Huertas, Maria Rosa
AU  - Coiras, Mayte
PY  - 2020
DO  - 10.1016/j.bcp.2020.114203
UR  - http://hdl.handle.net/20.500.12105/13934
AB  - Tyrosine kinase inhibitors (TKIs) are successfully used in clinic to treat chronic myeloid leukemia (CML). Our group previously described that CD4+ T cells from patients with CML on treatment with TKIs such as dasatinib were resistant to HIV-1...
LA  - eng
PB  - Elsevier
KW  - HIV-1
KW  - Viral reservoir
KW  - SAMHD1
KW  - Src tyrosine kinases
KW  - Chronic myeloid leukemia
KW  - Adult
KW  - Aged
TI  - Cytotoxic cell populations developed during treatment with tyrosine kinase inhibitors protect autologous CD4+ T cells from HIV-1 infection
TY  - research article
ER  -